Ligand validation:4KLY

RET: RETINAL

RET is a Ligand Of Interest in 4KLY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4KLY_RET_C_301	39%	7%	0.224	0.93	1.4	3.3	1	11	6	0	100%	0.9524
4KLY_RET_B_301	38%	7%	0.226	0.928	1.08	3.67	1	12	4	0	100%	0.9524
4KLY_RET_E_301	34%	8%	0.238	0.921	0.84	3.67	-	16	2	0	100%	0.9524
4KLY_RET_A_301	26%	6%	0.27	0.911	0.96	4.09	-	14	2	0	100%	0.9524
4KLY_RET_D_301	16%	9%	0.304	0.88	0.87	3.5	-	14	1	0	100%	0.9524
4KNF_RET_C_301	41%	8%	0.236	0.954	0.93	3.63	1	16	4	0	100%	0.9524
7XJE_RET_A_301	99%	6%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
7XJC_RET_A_301	97%	10%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752
7XJD_RET_A_301	97%	10%	0.06	0.972	1.93	2.42	2	14	0	0	100%	0.9524
5ZIN_RET_A_250	96%	6%	0.054	0.964	2.81	2.16	4	10	0	0	100%	0.9524
6TK7_RET_A_301	96%	63%	0.059	0.967	0.85	0.59	1	-	1	0	100%	0.9524

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.